Express Scripts Articles
Express Scripts adds Vivus' Qsymia to its standard benefits program
20 December 2012
Flaws in ESI/Medco efficiency claims exposed
20 February 2012
Showing 1-3 of 3 articles
- 1
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
